<DOC>
	<DOCNO>NCT02016235</DOCNO>
	<brief_summary>Patients Dent disease suppress level FGF 23 contributes hypercalciuria , kidney stone , nephrocalcinosis renal failure . Supplementation phosphorus may reduce hypercalciuria .</brief_summary>
	<brief_title>Role Of Phosphorus And FGF 23 In Patients With Dent Disease</brief_title>
	<detailed_description />
	<mesh_term>Dent Disease</mesh_term>
	<criteria>1 . Patients recruit RKSC Dent Registry Diagnostic criterion Dent disease include : A . 1 . LMWP ( least 5 time upper limit normal ) least 1 follow criterion : 1 . Hypercalciuria , 2 . Kidney stone , 3 . Nephrocalcinosis , 4 . Hypophosphatemia , 5 . Renal phosphate leak , 6 . Aminoaciduria , 7 . Glucosuria without diabetes mellitus , 8 . Hematuria , 9 . Renal insufficiency , 10 . Family history xlinked inheritance B . 1 criterion ( 19 ) confirm genetic mutation CLCN5 OCRL1 . 2 . Idiopathic calcium nephrolithiasis renal phosphate leak 1 . Male patient &gt; 18 year old 2 . History symptomatic calcium oxalate calcium phosphate stone , hypercalciuria ( &gt; 250 mg/24 hr ) , renal phosphate leak ( TMP/GFR &lt; 2.07 mg/dl ) 3 . Idiopathic calcium nephrolithiasis without renal phosphate leak 1 . Male patient &gt; 18 year old 2 . History symptomatic calcium oxalate calcium phosphate stone , hypercalciuria ( &gt; 250 mg/24 hr ) , renal phosphate leak ( TMP/GFR &lt; 2.07 mg/dl ) 1 . Exclusion Dent disease include : primary secondary hyperparathyroidism , hyperthyroidism , chronic diarrhea state ; intake thiazide diuretic , glucocorticoid , estrogen within one month study . 2 . Exclusion criterion calcium stone former include : primary secondary hyperparathyroidism , hyperthyroidism , estimate GFR &lt; 40 ml/mn/1.73m2 , chronic diarrhea state ; intake thiazide diuretic , glucocorticoid , estrogen within one month study . 3 . Exclusion criterion include history symptomatic asymptomatic kidney stone disease ; primary secondary hyperparathyroidism ; estimate GFR &lt; 40 ml/min/1.73m2 , chronic diarrhea state ; intake thiazide diuretic , glucocorticoid , estrogen within one month study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Dent</keyword>
	<keyword>Dents</keyword>
	<keyword>Dent Disease</keyword>
	<keyword>Phosphorus Supplements</keyword>
	<keyword>FGF 23</keyword>
</DOC>